CFDE Data Portal | Search INSR

	Label	Description
	INSR Gene (Entity type)	ENSG00000171105 - insulin receptor
	CISH Gene (Entity type)	ENSG00000114737 - cytokine inducible SH2 containing protein
	MAPK9 Gene (Entity type)	ENSG00000050748 - mitogen-activated protein kinase 9
	PPP2CB Gene (Entity type)	ENSG00000104695 - protein phosphatase 2 catalytic subunit beta
	INSR associations Collection (Entity type)	Associations for INSR_associations
	PPM1B Gene (Entity type)	ENSG00000138032 - protein phosphatase, Mg2+/Mn2+ dependent 1B
	CAD Gene (Entity type)	ENSG00000084774 - carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
	GSE102505 5 V 0 TUNICAMYCIN HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE135514 8 V 7 DASATINIB HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE135350 2 V 4 DEXAMETHASONE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS

INSR

ENSG00000171105 - insulin receptor

CISH

ENSG00000114737 - cytokine inducible SH2 containing protein

MAPK9

ENSG00000050748 - mitogen-activated protein kinase 9

PPP2CB

ENSG00000104695 - protein phosphatase 2 catalytic subunit beta

INSR associations

Associations for INSR_associations

PPM1B

ENSG00000138032 - protein phosphatase, Mg2+/Mn2+ dependent 1B

CAD

ENSG00000084774 - carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase

GSE102505 5 V 0 TUNICAMYCIN HUMAN DN

A Gene Set from LINCS

GSE135514 8 V 7 DASATINIB HUMAN DN

A Gene Set from LINCS

GSE135350 2 V 4 DEXAMETHASONE HUMAN UP

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.